CDN1163
CAS No. 892711-75-0
CDN1163 ( CDN 1163 | CDN-1163 )
产品货号. M16438 CAS No. 892711-75-0
CDN1163 (CDN-1163) 是 SERCA2 的小分子变构激活剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥377 | 有现货 |
|
| 5MG | ¥606 | 有现货 |
|
| 10MG | ¥938 | 有现货 |
|
| 25MG | ¥1841 | 有现货 |
|
| 50MG | ¥3320 | 有现货 |
|
| 100MG | ¥4707 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥654 | 有现货 |
|
生物学信息
-
产品名称CDN1163
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述CDN1163 (CDN-1163) 是 SERCA2 的小分子变构激活剂。
-
产品描述CDN1163 (CDN-1163) is a small molecule, allosteric activator of SERCA2, dose-dependently increases the Vmax of SERCA2 Ca2+-ATPase activity in ER microsomes; increases Ca2+-ATPase activity and significantly enhances Ca2+ uptake into the ER, attenuates H2O2-stimulated cell death in HEK cells; improves glucose homeostasis and metabolic parameters, increases glucose tolerance in ob/ob mice; CDN1163 reduces lipid accumulation and decreases lipogenesis in obese mice livers.
-
体外实验CDN1163 (10μM; 24 hours; rat cardiac myocyte cells) treatment reduces high glucose-induced resistin and nuclear NFATc expression and increases the phosphorylation of AMPKα in a time-dependent manner. Western Blot Analysis Cell Line:Rat cardiac myocyte cells (H9c2)Concentration:10?μM Incubation Time:24 hours Result:High glucose-induced resistin and nuclear NFATc expression are significantly reduced. The phosphorylation of AMPKα is increased in a time-dependent manner.
-
体内实验CDN1163 (50 mg/kg; intraperitoneal injection; for 5 days; male ob/ob mice and lean ob/+ mice) increases SERCA2 Ca2+-ATPase activity, decreases endoplasmic reticulum (ER) stress-induced cell death in vitro and improves liver Ca2+ transport activity. CDN1163 reduces blood glucose levels and improves metabolic parameters and gluconeogenic gene expression, reverses hepatic steatosis, inhibits ER stress and ER stress-induced apoptosis, and improves mitochondrial efficiency in ob/ob mice in vivo. Animal Model:Male 8-10-week old ob/ob mice and lean ob/+ mice Dosage:50 mg/kg Administration:Intraperitoneal injection; for 5 days Result:Markedly lowered fasting blood glucose, improved glucose tolerance, and ameliorated hepatosteatosis but did not alter glucose levels or body weight. Increased expression of uncoupling protein 1 (UCP1) and UCP3 in brown adipose tissue and reduced the hepatic expression of genes involved in gluconeogenesis and lipogenesis, attenuated ER stress response and ER stress-induced apoptosis, and improved mitochondrial biogenesis, possibly through SERCA2-mediated activation of AMP-activated protein kinase pathway.
-
同义词CDN 1163 | CDN-1163
-
通路GPCR/G Protein
-
靶点Calcium Channel
-
受体Calcium Channel
-
研究领域——
-
适应症——
化学信息
-
CAS Number892711-75-0
-
分子量320.392
-
分子式C20H20N2O2
-
纯度>98% (HPLC)
-
溶解度DMSO : 50 mg/mL 156.06 mM; H2O : < 0.1 mg/mL
-
SMILESO=C(NC1=C2N=C(C)C=CC2=CC=C1)C3=CC=C(OC(C)C)C=C3
-
化学全称4-(1-Methylethoxy)-N-(2-methyl-8-quinolinyl)benzamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Krajnak K, et al. Bioorg Med Chem Lett. 2018 May 15;28(9):1591-1594.
2. Kang S, et al. J Biol Chem. 2016 Mar 4;291(10):5185-98.
3. Dahl R. Bioorg Med Chem. 2017 Jan 1;25(1):53-57.
4. Cornea RL, et al. J Biomol Screen. 2013 Jan;18(1):97-107.
产品手册
关联产品
-
Mirogabalin
Mirogabalin (DS-5565) 是电压门控钙通道 α2δ 亚基的新型有效选择性配体,对人 α2δ-1、人 α2δ-2、大鼠 α2δ-1 和大鼠 α2δ-1 的 Kd 为 13.5/22.7/27.0/47.6 nM分别为大鼠α2δ-2亚基。
-
Mibefradil dihydroch...
Mibefradil diHClide 是一种钙通道阻滞剂,对 T 型 Ca2+ 通道具有中等选择性(T 型和 L 型电流的 IC50 分别为 2.7 μM 和 18.6 μM)。 Mibefradil diHClide 可逆地抑制 T 型和 L 型电流,IC50 值分别为 2.7 和 18.6 μM。
-
Diltiazem hydrochlor...
一种突触后肌肉松弛剂,可抑制肌浆网储存的 Ca2+ 离子释放;拮抗兰尼碱受体。
021-51111890
购物车()
sales@molnova.cn

